Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000478597 | SCV000570851 | uncertain significance | not provided | 2016-06-30 | criteria provided, single submitter | clinical testing | This variant is denoted ATM c.1905C>T at the DNA level. This variant is silent at the coding level, preserving a Histidine at codon 635. This variant has not, to our knowledge, been published in the literature as being pathogenic or benign. In silico splicing models are uninformative, therefore, in the absence of RNA or functional studies, the actual effect of this variant is unknown. ATM c.1905C>T was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations.The nucleotide which is altered, a cytosine (C) at base 1905, is not conserved. Based on currently available information, it is unclear whether ATM c.1905C>T is a pathogenic or benign variant. We consider it to be a variant of uncertain significance. |
Ambry Genetics | RCV000575131 | SCV000660769 | likely benign | Hereditary cancer-predisposing syndrome | 2017-04-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000575131 | SCV001349666 | likely benign | Hereditary cancer-predisposing syndrome | 2019-04-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001475097 | SCV001679284 | likely benign | Ataxia-telangiectasia syndrome | 2023-11-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002307518 | SCV002600332 | likely benign | not specified | 2022-10-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004591427 | SCV005084531 | benign | Familial cancer of breast | 2024-05-02 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |